Icahn Says $8B Illumina-Grail Deal Caused Millions In Losses

By Katryna Perera ( October 23, 2023, 3:45 PM EDT) -- Carl Icahn alleges in a proposed securities class and derivative action filed in Delaware's Chancery Court that Illumina Inc. and its board of directors breached their fiduciary duties to stockholders and caused millions of dollars in losses to the biotech company by pushing through its $8 billion reacquisition of cancer testing company Grail Inc....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!